Aetion
Amelia Boehme currently serves as the Director of Science at Aetion, a position held since July 2022. Concurrently, Amelia is an Assistant Professor of Epidemiology in Neurology at Columbia University Medical Center, where involvement includes responsibilities as a Neuroepidemiology Fellow focused on data acquisition, analysis, interpretation, manuscript, and grant preparation since June 2014. Amelia's academic journey began at the University of Alabama at Birmingham, where a Doctor of Philosophy (PhD) in Epidemiology was earned from 2010 to 2014, alongside a Master of Science in Public Health in Epidemiology from 2008 to 2010. Research interests encompass drug-gene interactions with anti-thrombotic medications in heart failure patients and statistical methodology, particularly causal inference.
This person is not in the org chart
This person is not in any teams
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.